These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36890170)

  • 21. Alternative stable conformation capable of protein misinteraction links tRNA synthetase to peripheral neuropathy.
    Blocquel D; Li S; Wei N; Daub H; Sajish M; Erfurth ML; Kooi G; Zhou J; Bai G; Schimmel P; Jordanova A; Yang XL
    Nucleic Acids Res; 2017 Jul; 45(13):8091-8104. PubMed ID: 28531329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between Neurological Diseases and Mutations in the Human Glycyl-tRNA Synthetase.
    Vinogradova ES; Nikonov OS; Nikonova EY
    Biochemistry (Mosc); 2021 Jan; 86(Suppl 1):S12-S23. PubMed ID: 33827397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The GARS gene is rarely mutated in Japanese patients with Charcot-Marie-Tooth neuropathy.
    Abe A; Hayasaka K
    J Hum Genet; 2009 May; 54(5):310-2. PubMed ID: 19329989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement].
    Kawakami N; Komatsu K; Yamashita H; Uemura K; Oka N; Takashima H; Takahashi R
    Rinsho Shinkeigaku; 2014; 54(11):911-5. PubMed ID: 25420567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel partial loss-of-function variants in the tyrosyl-tRNA synthetase 1 (YARS1) gene involved in multisystem disease.
    Estève C; Roman C; DeLeusse C; Baravalle M; Bertaux K; Blanc F; Bourgeois P; Bresson V; Cano A; Coste ME; Delteil C; Lacoste C; Loosveld M; De Paula AM; Monnier AS; Secq V; Levy N; Badens C; Fabre A
    Eur J Med Genet; 2021 Oct; 64(10):104294. PubMed ID: 34352414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.
    Seburn KL; Nangle LA; Cox GA; Schimmel P; Burgess RW
    Neuron; 2006 Sep; 51(6):715-26. PubMed ID: 16982418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional dysregulation by a nucleus-localized aminoacyl-tRNA synthetase associated with Charcot-Marie-Tooth neuropathy.
    Bervoets S; Wei N; Erfurth ML; Yusein-Myashkova S; Ermanoska B; Mateiu L; Asselbergh B; Blocquel D; Kakad P; Penserga T; Thomas FP; Guergueltcheva V; Tournev I; Godenschwege T; Jordanova A; Yang XL
    Nat Commun; 2019 Nov; 10(1):5045. PubMed ID: 31695036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
    Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM
    Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare variants in methionyl- and tyrosyl-tRNA synthetase genes in late-onset autosomal dominant Charcot-Marie-Tooth neuropathy.
    Hyun YS; Park HJ; Heo SH; Yoon BR; Nam SH; Kim SB; Park CI; Choi BO; Chung KW
    Clin Genet; 2014 Dec; 86(6):592-4. PubMed ID: 24354524
    [No Abstract]   [Full Text] [Related]  

  • 30. SIRT2-knockdown rescues GARS-induced Charcot-Marie-Tooth neuropathy.
    Zhao Y; Xie L; Shen C; Qi Q; Qin Y; Xing J; Zhou D; Qi Y; Yan Z; Lin X; Dai R; Lin J; Yu W
    Aging Cell; 2021 Jun; 20(6):e13391. PubMed ID: 34053152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).
    McLaughlin HM; Sakaguchi R; Giblin W; ; Wilson TE; Biesecker L; Lupski JR; Talbot K; Vance JM; Züchner S; Lee YC; Kennerson M; Hou YM; Nicholson G; Antonellis A
    Hum Mutat; 2012 Jan; 33(1):244-53. PubMed ID: 22009580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase.
    He W; Bai G; Zhou H; Wei N; White NM; Lauer J; Liu H; Shi Y; Dumitru CD; Lettieri K; Shubayev V; Jordanova A; Guergueltcheva V; Griffin PR; Burgess RW; Pfaff SL; Yang XL
    Nature; 2015 Oct; 526(7575):710-4. PubMed ID: 26503042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathy-associated histidyl-tRNA synthetase variants attenuate protein synthesis in vitro and disrupt axon outgrowth in developing zebrafish.
    Mullen P; Abbott JA; Wellman T; Aktar M; Fjeld C; Demeler B; Ebert AM; Francklyn CS
    FEBS J; 2021 Jan; 288(1):142-159. PubMed ID: 32543048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases.
    Wei N; Zhang Q; Yang XL
    J Biol Chem; 2019 Apr; 294(14):5321-5339. PubMed ID: 30643024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Genetic Features in a Series of Eight Unrelated Patients with Neuropathy Due to Glycyl-tRNA Synthetase (GARS) Variants.
    Forrester N; Rattihalli R; Horvath R; Maggi L; Manzur A; Fuller G; Gutowski N; Rankin J; Dick D; Buxton C; Greenslade M; Majumdar A
    J Neuromuscul Dis; 2020; 7(2):137-143. PubMed ID: 31985473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathic pain model of peripheral neuropathies mediated by mutations of glycyl-tRNA synthetase.
    Lee SJ; Seo AJ; Park BS; Jo HW; Huh Y
    J Korean Med Sci; 2014 Aug; 29(8):1138-44. PubMed ID: 25120326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.
    Motley WW; Seburn KL; Nawaz MH; Miers KE; Cheng J; Antonellis A; Green ED; Talbot K; Yang XL; Fischbeck KH; Burgess RW
    PLoS Genet; 2011 Dec; 7(12):e1002399. PubMed ID: 22144914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease.
    Malissovas N; Griffin LB; Antonellis A; Beis D
    Hum Mol Genet; 2016 Apr; 25(8):1528-42. PubMed ID: 27008886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy.
    Lee AJ; Nam DE; Choi YJ; Nam SH; Choi BO; Chung KW
    Genes Genomics; 2020 Jun; 42(6):663-672. PubMed ID: 32314272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral neuropathy via mutant tRNA synthetases: Inhibition of protein translation provides a possible explanation.
    Storkebaum E
    Bioessays; 2016 Sep; 38(9):818-29. PubMed ID: 27352040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.